Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FPRP4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,465
Award facts
- Contract value 100% obligated
- $9,464.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $9,464.50 by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of Nucala 100 mg/ml auto-injectors. The contract carries a firm fixed-price structure with no set-aside designation and an ultimate completion date of September 26, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026.
The DLA's SPE2DB contract vehicle enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, medical consumables, and specialty medications including auto-injectors and injection-based therapies. The company's performance under this expansive contract portfolio demonstrates its capacity to provide reliable pharmaceutical distribution directly to Department of Defense healthcare sites on a nationwide and global basis.
Quick answers
Who was awarded contract SPE2DB25FPRP4?
SPE2DB25FPRP4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FPRP4 worth?
The government has obligated $9,465 on SPE2DB25FPRP4.
Is contract SPE2DB25FPRP4 an order under another contract?
Yes. SPE2DB25FPRP4 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRP4 competed?
The extent of competition for SPE2DB25FPRP4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award